Trial Profile
Clinical Trials Insight: 700034470
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Mar 2010
Price :
$35
*
At a glance
- Drugs Silodosin (Primary) ; Moxifloxacin
- Indications Bacterial infections; Benign prostatic hyperplasia; Lower urinary tract symptoms
- Focus Adverse reactions
- Sponsors Actavis Inc
- 10 Mar 2010 Results published in Clinical Pharmacology and Therapeutics.
- 29 Sep 2008 Added ref.
- 12 Jun 2008 New trial record.